[1] |
Luo, Q.Z. Study on prevention and treatment of calf diarrhea with traditional Chinese medicine. Chin. J. Trad. Vet. Sci. 2019, 3, 55.
|
[2] |
Wang, Z.B. Reasons and control measures of diarrhea in broilers. Mod. Anim. Husb. 2017, 9, 27.
|
[3] |
Wei, H.; Li, J.J.; Wang, W.H. Reasons for colibacilosis in pig and control measures. Shaanxi J. Agr. Sci. 2018, 64, 92–95.
|
[4] |
Chen, C.R.; Han, M.M.; Zhang, N.J.; Wang, W.B.; Yao, Y.B.; Xiao, S.; Li, Y. Association of biofilm formation with drug-resistance and virulence of Escherichia coli isolated from diarrhea piglet. Microbiol. China. 2016, 43, 2234–2241.
|
[5] |
Seki, E.; Schnabl, B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J. Physiol. 2012, 590, 447–458.
|
[6] |
Hakansson, A.; Molin, G. Gut microbiota and inflammation. Nutrients. 2011, 3, 637–682.
|
[7] |
Chinese, VPC Veterinary pharmacopoeia of the people’s republic of China. Volume III. China Agricultural Press. 2011, 235.
|
[8] |
Huang, H.H.; Zhen, H.S. Research progress of Polygonum hydropiper L. in recent years. Chin. J. Ethnomed. Ethnopharm. 2013, 22, 38–40.
|
[9] |
Yu, X.; Li, W. Research progress on the regulation of cytochrome P450 expression in inflammatory diseases. J. Dalian Med. Univ. 2017, 39, 87–91.
|
[10] |
Song, F.X.; Wang, R.; Yuan, Y.F. Application progress in cytochrome P450 enzymes and research methods of drug metabolism. Med. Recapit. 2017, 23, 665–669.
|
[11] |
Tian, M.Y.; Fan, J.H.; Zhuang, Z.W.; Dai, F.; Wang, C.Y.; Hou, H.T.; Ma, Y.Z. Effects of silymarin on p65 NF-κB, p38 MAPK and CYP450 in LPS-induced hoof dermal inflammatory cells of dairy cows. BMC Vet. Res. 2019, 15, 127.
|
[12] |
Chen, Y.; Li, S.; Su, P.; Zhang, H.J.; Zhang, G.P.; Ye, Z.G. Anti-diarrhea effect and mechanism of traditional Chinese medicine. Chin. J. Exp. Tradit. Med. Formulae. 2019, 25, 203–211.
|
[13] |
Hu, N.; Huang, Y.J.; Gao, X.J.; Li, S.; Yan, Z.X.; Wei, B.; Yan, R. Effects of dextran sulfate sodium induced experimental colitis on cytochrome P450 activities in rat liver, kidney and intestine. Chem. Biol. Interact. 2017, 271, 48–58.
|
[14] |
Xiao, Z.H.; Luo, X.Y.; Cheng, X.X.; Zheng, S.J.; Yang, Q.; Yang, H.W. Effect of polygoni hydropiperis herba on intestinal mucosal repair in diarrhea mice induced by escherichia coli. Chin. J. Exp. Tradit. Med. Formulae. 2018, 24, 120–126.
|
[15] |
Kawauchi, S.; Nakamura, T.; Yasui, H.; Nishikawa, C.; Miki, I.; Inoue, J.; Horibe, S.; Hamaguchi, T.; Tanahashi, T.; Mizuno, S. Intestinal and hepatic expression of cytochrome P450s and mdr1a in rats with indomethacin-induced small intestinal ulcers. Int. J. Med. Sci. 2014, 11, 1208–1217.
|
[16] |
Zheng, S.F.; Jin, X.; Chen, M.H.; Shi, Q.X.; Zhang, H.F.; Xu, S.W. Hydrogen sulfide exposure induces jejunum injury via CYP450s/ROS pathway in broilers. Chemosphere. 2019, 214, 25–34.
|
[17] |
Xie, F.; Ding, X.X.; Zhang, Q.Y. An update on the role of intestinal cytochrome P450 enzymes in drug disposition. Acta Pharm. Sin. B. 2016, 6, 374–383.
|
[18] |
Almazroo, O.A.; Miah, M.K.; Venkataramanan, R. Drug metabolism in the liver. Clin. Liver Dis. 2017, 21, 1–20.
|
[19] |
Gideon, D.A.; Kumari, R.; Lynn, A.M.; Manoj, K.M. What is the functional role of N-terminal transmembrane helices in the metabolism mediated by liver microsomal cytochrome P450 and its reductase? Cell Biochem. Biophys. 2012, 63, 35–45.
|
[20] |
Zhou, X.Y.; Tian, LX; Huang, Q.; Liang, H.P. Research progress on the relationship between cytochrome P4501A1 (CYP1A1) and immune diseases. Infection Inflammation Repair. 2017, 18, 120–124.
|
[21] |
Gonzalez, J.; Marchand-Geneste, N.; Giraudel, J.L.; Shimada, T. Docking and QSAR comparative studies of polycyclic aromatic hydrocarbons and other procarcinogen interactions with cytochromes P450 1A1 and 1B1. SAR QSAR Environ. Res. 2012, 23, 87–109.
|
[22] |
Liu, M.C.; Meng, Q.Q.; Cui, J.H.; Li, S.S. Recent research progress on the CYP1B1 inhibitors. Prog. Mod. Biomed. 2017, 17, 4190–4196.
|
[23] |
Udomsuk, L.; Juengwatanatrakul, T.; Putalun, W.; Jarukamjorn, K. Bimodal action of miroestrol and deoxymiroestrol, phytoestrogens from Pueraria candollei var. mirifica, on hepatic CYP2B9 and CYP1A2 expressions and antilipid peroxidation in mice. Nutr. Res. 2012, 32, 45–51.
|
[24] |
Pan, Y.J.; Omori, K.; Ali, I.; Tachikawa, M.; Terasaki, T.; Brouwer, K.L.R.; Nicolazzo, J.A. Altered expression of small intestinal drug transporters and hepatic metabolic enzymes in a mouse model of familial Alzheimer’s disease. Mol. Pharm. 2018, 15, 4073–4083.
|
[25] |
Zhang, L.Q.; Ba, L.; Yu, S.; Ha, S. Advance in cytochrome P450 2J subfamily. Prog. Vet. Med. 2014, 35, 84–89.
|
[26] |
Madanayake, T.W.; Fidler, T.P.; Fresquez, T.M.; Bajaj, N.; Rowland, A.M. Cytochrome P450 2S1 depletion enhances cell proliferation and migration in bronchial epithelial cells, in part, through modulation of prostaglandin E(2) synthesis. Drug Metab. Dispos. Biol. Fate Chem. 2012, 40, 2119–2125.
|
[27] |
Zhao, C. Expression detection and phenotypic analysis of cytochrome CYP3A11 knock down mice. D. Southwest Univ. 2011.
|
[28] |
Thesseling, F.A.; Hutter, M.C.; Wiek, C.; Kowalski, J.P.; Rettie, A.E.; Girhard, M. Novel insights into oxidation of fatty acids and fatty alcohols by cytochrome P450 monooxygenase CYP4B1. Arch. Biochem. Biophys. 2020, 679, 108216.
|
[29] |
Barć, J.; Karpeta, A.; Gregoraszczuk, E.Ł. Action of halowax 1051 on enzymes of phase I (CYP1A1) and phase II (SULT1A and COMT) metabolism in the pig ovary. Int. J. Endocrinol. 2013, 2013, 590261.
|
[30] |
Lian-Sheng, W. Progress in down-regulation of cytochrome P450 enzyme activities and mechanisms during inflammation. Chin. J. Pharm. Toxicol. 2010, 24, 236–240.
|
[31] |
Gandhi, A.; Moorthy, B.; Ghose, R. Drug disposition in pathophysiological conditions. Curr. Drug Metab. 2012, 13, 1327–1344.
|
[32] |
Monshouwer, M.; Witkamp, R.F. Cytochromes and cytokines: changes in drug disposition in animals during an acute phase response: a mini-review. Vet. Q. 2000, 22, 17–20.
|
[33] |
Lee, C.M.; Pohl, J.; Morgan, E.T. Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures. Drug Metab. Dispos. Biol. Fate Chem. 2009, 37, 865–872.
|
[34] |
Stejskalova, L.; Pavek, P. The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta. Curr. Pharm. Biotechnol. 2011, 12, 715–730.
|
[35] |
Li, F.; Zhu, W.F.; Gonzalez, F.J. Potential role of CYP1B1 in the development and treatment of metabolic diseases. Pharmacol. Ther. 2017, 178, 18–30.
|
[36] |
Zhao, Y.Y.; Yao, X.P.; Jiao, T.Y.; Tian, J.N.; Gao, Y.; Fan, S.C.; Chen, P.P.; Jiang, Y.M.; Zhou, Y.Y.; Chen, Y.X.; Yang, X.; Huang, M.; Bi, H.C. Schisandrol B promotes liver enlargement via activation of PXR and YAP pathways in mice. Phytomedicine. 2021, 84, 153520.
|
[37] |
Ye, Z.; Liu, Z.P.; Henderson, A.; Lee, K.; Hostetter, J.; Wannemuehler, M.; Hendrich, S. Increased CYP4B1 mRNA is associated with the inhibition of dextran sulfate sodium-induced colitis by caffeic acid in mice. Exp. Biol. Med. (Maywood ). 2009, 234, 605–616.
|